Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from Russell Microcap Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.305 USD | +1.95% |
|
-1.88% | -11.22% |
May. 15 | Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M | MT |
May. 15 | Spero Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.22% | 70.45M | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.11% | 26.22B | |
-25.37% | 19.01B | |
-20.02% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Spero Therapeutics, Inc.(NasdaqGS: SPRO) dropped from Russell Microcap Value Index